CDC releases 2024 immunization schedules for all age groups. FDA approves first OTC test for chlamydia and gonorrhea. CDC: Vaccine exemptions for kindergartners at highest level. FDA warns of potential lethal reaction to certain seizure meds. Pharmacists’ role in BP control saves significant U.S. health care dollars. Has generic imatinib reduced Medicare beneficiaries’ cost for this expensive drug?

Artificial intelligence (AI) is the capacity of machines to perform tasks that would ordinarily require human intelligence, including sensing, thinking, learning, and decision-making.

Kristin Wiisanen PharmD, FAPhA, FCCP, Pharmacy Today editor in chief

We’ve all been running hard. We barely get a good night’s sleep when it’s time to get up, get to the pharmacy or hospital or office, and then the day is a blur.

Michael D. Hogue PharmD, FAPhA, FNAP, FFIP Executive vice president and CEO of APhA

The legislative, regulatory, societal, and economic issues impacting the pharmacy community in 2023 resulted in some wins, some losses, and some continuing challenges that will carry into 2024.

Trending Topics

An estimated 1.6 million to 3.8 million nursing home residents acquire a health care–associated infection each year. It’s one of the most common reasons for hospitalization and even death in this patient population.

Loren Bonner

In the dynamic landscape of HIV prevention and treatment, the U.S. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV are at the forefront.

Corey Diamond, PharmD

For clinicians who work in acute care settings, some practical guidance pertaining to drug–drug interactions (DDIs) for the treatment of patients with COVID-19 is finally available.

Loren Bonner

APhA Member News